Table 1 Indication for and added clinical value of clinician-initiated blood smear reviews
Indication | Smears for this indication, among all smears performed (%) | Smears with added clinical value, among smears performed for this indication (%) |
|---|---|---|
Any | 515 (100%) | 118 (23%) |
Any RBC abnormality | 259 (50%) | 48 (19%)a |
Any WBC cell abnormality | 126 (24%) | 32 (25%)a |
Any PLT abnormality | 150 (29%) | 20 (13%)a |
Any cytosis | 53 (10%) | 18 (34%) |
Erythrocytosis | 2 (0%) | 0 (0%) |
Leukocytosis | 42 (8%) | 18 (43%) |
Thrombocytosis | 12 (2%) | 1 (8%) |
Any cytopenia | 267 (52%) | 45 (17%) |
Anemia | 179 (35%) | 32 (18%) |
Leukopenia | 79 (15%) | 11 (14%) |
Thrombocytopenia | 135 (26%) | 18 (13%) |
Any abnormal cell morphology | 39 (8%) | 9 (23%) |
RBC morphology | 22 (4%) | 4 (18%) |
WBC morphology | 6 (1%) | 3 (50%) |
PLT morphology | 5 (1%) | 1 (20%) |
Hematolymphoid neoplasm | 65 (13%) | 30 (46%) |
Blasts | 5 (1%) | 2 (40%) |
Hemolysis | 100 (19%) | 24 (24%) |
Parasites | 4 (1%) | 1 (25%) |
Other | 55 (11%) | 15 (27%) |
Not specified | 33 (6%) | 6 (18%) |